{"generation": 91, "stage": "population", "candidate_idx": 0, "weights": {"risk_aversion": 0.19999980000020004, "herd_behavior": 0.3999996000004001, "profit_driven": 0.3999996000004001}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, so any adjustment would likely be modest.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 1, "weights": {"risk_aversion": 0.44999955000045005, "herd_behavior": 0.04999995000005001, "profit_driven": 0.49999950000050003}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 2, "weights": {"risk_aversion": 0.24999975000025002, "herd_behavior": 0.34999965000035, "profit_driven": 0.3999996000004001}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 3, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.09999990000010002, "profit_driven": 0.49999950000050003}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 4, "weights": {"risk_aversion": 0.19999980000020004, "herd_behavior": 0.19999980000020004, "profit_driven": 0.5999994000006}, "mean_reward": -0.04491448745510791, "std_reward": 0.0, "mean_abs_error": 0.04491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.04, "abs_error": 0.04491448745510791, "reward": -0.04491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 5, "weights": {"risk_aversion": 0.49999950000050003, "herd_behavior": 0.24999975000025002, "profit_driven": 0.24999975000025002}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 6, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.49999950000050003, "profit_driven": 0.19999980000020004}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 7, "weights": {"risk_aversion": 0.5499994500005501, "herd_behavior": 0.19999980000020004, "profit_driven": 0.24999975000025002}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 8, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.44999955000045005, "profit_driven": 0.14999985000015}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's previous quarter volatility is moderately high (0.282), which could temper the magnitude of the increase due to risk management considerations. The fund's current holding is substantial relative to its AUM, suggesting limited room for large incremental changes, so any adjustment would likely be modest.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 9, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.34999965000035, "profit_driven": 0.2999997000003}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 10, "weights": {"risk_aversion": 0.49999950000050003, "herd_behavior": 0.3999996000004001, "profit_driven": 0.09999990000010002}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 11, "weights": {"risk_aversion": 0.44999955000045005, "herd_behavior": 0.34999965000035, "profit_driven": 0.19999980000020004}, "mean_reward": -0.03491448745510791, "std_reward": 0.0, "mean_abs_error": 0.03491448745510791, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 210, "quarter": "NA", "permno": 76744, "date": "2017-07-01 00:00:00", "holding_t": 5118.977367, "ticker": "VRTX", "company": "VERTEX PHARMACEUTICALS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": 0.00491448745510791, "pred": -0.03, "abs_error": 0.03491448745510791, "reward": -0.03491448745510791, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.176) and strong asset growth (Gat=0.169), alongside its elevated beta (1.681) indicating higher systematic risk, a growth-oriented investor might increase exposure to capture potential upside. However, the stock's high volatility (stock_vol_q_prev=0.282) and the fund's substantial AUM relative to the position size suggest caution, potentially limiting the magnitude of the increase. The current holding is already significant relative to the stock's S&P 500 weight, which may temper further allocation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 0, "weights": {"risk_aversion": 0.24999975000025002, "herd_behavior": 0.24999975000025002, "profit_driven": 0.49999950000050003}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), alongside its low beta (0.6759) indicating lower systematic risk, the stock appears fundamentally sound but not exceptionally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. Considering the modest fundamental signals and the fund's existing low exposure, a slight increase in holding might be expected to align with the stock's stable profile, though the magnitude would likely be modest due to the lack of strong catalysts.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 1, "weights": {"risk_aversion": 0.5499994500005501, "herd_behavior": 0.24999975000025002, "profit_driven": 0.19999980000020004}, "mean_reward": -0.024024834201145432, "std_reward": 0.0, "mean_abs_error": 0.024024834201145432, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.02, "abs_error": 0.024024834201145432, "reward": -0.024024834201145432, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 2, "weights": {"risk_aversion": 0.24999975000025002, "herd_behavior": 0.34999965000035, "profit_driven": 0.3999996000004001}, "mean_reward": -0.03402483420114543, "std_reward": 0.0, "mean_abs_error": 0.03402483420114543, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.01, "abs_error": 0.03402483420114543, "reward": -0.03402483420114543, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.01}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 3, "weights": {"risk_aversion": 0.49999950000050003, "herd_behavior": 0.2999997000003, "profit_driven": 0.19999980000020004}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 4, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.14999985000015, "profit_driven": 0.44999955000045005}, "mean_reward": -0.004024834201145432, "std_reward": 0.0, "mean_abs_error": 0.004024834201145432, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.04, "abs_error": 0.004024834201145432, "reward": -0.004024834201145432, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 5, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.34999965000035, "profit_driven": 0.34999965000035}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), alongside its low beta (0.6759) indicating lower systematic risk, the stock appears fundamentally sound but not exceptionally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. Considering the modest fundamental signals and the fund's capacity to manage exposure without significant active trading constraints, a slight increase in holding might be expected to align with the positive growth signal, though the magnitude would likely be modest due to the stock's already low benchmark weight.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 6, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.34999965000035, "profit_driven": 0.34999965000035}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), alongside its low beta (0.6759) indicating lower systematic risk, the stock appears fundamentally sound but not exceptionally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. Considering the modest fundamental signals and the fund's capacity to manage exposure without significant active trading constraints, a slight increase in holding might be expected to align with the positive growth signal, though the magnitude would likely be modest due to the stock's already low benchmark weight.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 7, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.34999965000035, "profit_driven": 0.2999997000003}, "mean_reward": -0.004024834201145432, "std_reward": 0.0, "mean_abs_error": 0.004024834201145432, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.04, "abs_error": 0.004024834201145432, "reward": -0.004024834201145432, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), alongside its low beta (0.6759) indicating lower systematic risk, the stock appears fundamentally sound but not exceptionally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest increase in holding might be expected to align with the firm's stable profile, though the magnitude would likely be tempered by the existing low position size.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 8, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.19999980000020004, "profit_driven": 0.3999996000004001}, "mean_reward": -0.024024834201145432, "std_reward": 0.0, "mean_abs_error": 0.024024834201145432, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.02, "abs_error": 0.024024834201145432, "reward": -0.024024834201145432, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 9, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.3999996000004001, "profit_driven": 0.2999997000003}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), along with its low beta (0.676) indicating lower systematic risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With no extreme signals in volatility or liquidity, a modest increase in holding might be expected to align with the positive fundamentals and the fund's active growth orientation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 10, "weights": {"risk_aversion": 0.24999975000025002, "herd_behavior": 0.44999955000045005, "profit_driven": 0.2999997000003}, "mean_reward": -0.014024834201145434, "std_reward": 0.0, "mean_abs_error": 0.014024834201145434, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.03, "abs_error": 0.014024834201145434, "reward": -0.014024834201145434, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and positive asset growth (Gat=0.0331), alongside its low beta (0.676) indicating lower systematic risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With the fund having substantial AUM and the stock showing stable but not exceptional growth, a modest increase in holding might be expected to align with the firm's positive fundamentals without significant benchmark deviation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 91, "stage": "population", "candidate_idx": 11, "weights": {"risk_aversion": 0.24999975000025002, "herd_behavior": 0.3999996000004001, "profit_driven": 0.34999965000035}, "mean_reward": -0.004024834201145432, "std_reward": 0.0, "mean_abs_error": 0.004024834201145432, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 296, "quarter": "NA", "permno": 91849, "date": "2019-07-01 00:00:00", "holding_t": 2041.14537, "ticker": "BR", "company": "BROADRIDGE FINANCIAL SOLUTNS INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.04402483420114543, "pred": -0.04, "abs_error": 0.004024834201145432, "reward": -0.004024834201145432, "best_k": 1, "completion": "\n<think>Given the firm's moderate profitability (profit=0.5885) and low beta (0.6759), it appears stable but not high-growth. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark-driven pressure. With average volatility and trading volume, a modest adjustment to align with the fund's scale and the stock's market relevance is expected, likely resulting in a minimal normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
